-
公开(公告)号:US20170360873A1
公开(公告)日:2017-12-21
申请号:US15536416
申请日:2015-12-15
发明人: Benjamin J. Blencowe , Mathieu Quesnel-Vallieres , Manuel Irimia , Bushra Raj , Sabine P. Cordes
IPC分类号: A61K38/05 , G01N33/68 , A01K67/027 , C12Q1/68 , A61K49/00 , A61K31/7088
摘要: Methods for treatment and diagnosis of neurological disorders such as autism and autism spectrum disorder are disclosed. Also disclosed are modulators of alternative splicing regulators SRRM4 and/or SRRM3 for treating neurological disorders. Further disclosed are agents that modulate the expression of at least one splice variant for treating neurological disorders. Mouse models of neurological disorders having increased or decreased expression of SRRM4 and/or SRRM3 are also disclosed.
-
公开(公告)号:US10772928B2
公开(公告)日:2020-09-15
申请号:US15536416
申请日:2015-12-15
发明人: Benjamin J. Blencowe , Mathieu Quesnel-Vallieres , Manuel Irimia , Bushra Raj , Sabine P. Cordes
IPC分类号: A61K38/55 , A61K38/05 , A61K31/7088 , G01N33/68 , C12Q1/6883 , A61K38/46 , G01N33/50 , A01K67/027 , C07K14/47 , A61K45/06 , A61K31/713 , A61K49/00
摘要: Methods for treatment and diagnosis of neurological disorders such as autism and autism spectrum disorder are disclosed. Also disclosed are modulators of alternative splicing regulators SRRM4 and/or SRRM3 for treating neurological disorders. Further disclosed are agents that modulate the expression of at least one splice variant for treating neurological disorders. Mouse models of neurological disorders having increased or decreased expression of SRRM4 and/or SRRM3 are also disclosed.
-
公开(公告)号:US20220348910A1
公开(公告)日:2022-11-03
申请号:US17615007
申请日:2020-06-01
发明人: Thomas GONATOPOULOS-POURNATZIS , Michael AREGGER , Jason MOFFAT , Benjamin J. Blencowe , Kevin Brown , Shaghayegh Farhangmehr
摘要: A hybrid guide RNA (hgRNA) comprising a proximal spacer, a distal spacer, a type II CRISPR-Cas tracrRNA, and a type V CRISPR-Cas direct repeat. Also provided herein are further multiplexed hgRNAs comprising additional direct repeats and spacers as well as methods of making and using thereof. Libraries comprising said hgRNAs or components thereof, cells, kits and reagents employed in the making or use thereof are also provided.
-
-